An immune role for LRRK2 in mediating PD has been suggested (1), and the question of increased frequency of concomitant multiple sclerosis and LRRK2 G2019S-related PD (LRRK2 PD) has been raised (2). This evidence concerns the gene LRRK2 and Parkinson disease.